Evaluation of the Effect of Open-Air Walking Supported by Treadmill and Mobile Application on Cardiopulmonary Function and Quality of Life in Patients With Fibromyalgia Syndrome
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 54
- 试验地点
- 1
- 主要终点
- 6-minute walk test
研究概览
简要总结
While walking exercises performed outdoors are important within the scope of aerobic exercise, the continuity of outdoor walking exercises can be negatively affected by different weather conditions. Walking exercises performed indoors on a treadmill are a good option for patients in terms of increasing exercise continuity and patient compliance. Walking outdoors supported by a treadmill and mobile application may increase aerobic capacity and quality of life in patients with fibromyalgia syndrome, as well as reduce kinesiophobia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 25 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Be between the ages of 25 and 55
- •Have not engaged in regular physical activity for the past 3 months
- •Have been using the same medical treatment for at least 1 month prior to the study (amitriptyline, duloxetine/milnacipran, pregabalin, cyclobenzaprine)
- •Volunteering to participate in the study
- •The patient's cognitive status being suitable for using a mobile application
- •The patient agreeing to the 'Personal Data Protection Law Information Text' in order to use the mobile application
排除标准
- •History of cardiac or pulmonary disease
- •Changes in medical treatment during the study period
- •Use of different injection methods (ozone therapy, neural therapy, acupuncture, etc.) at least 3 months prior to the study or during the study period
- •History of rheumatological disease
- •Pregnancy or breastfeeding
- •History of malignancy
- •Presence of psychiatric or neurological disease
研究组 & 干预措施
Open air walking
干预措施: Walking exercises at open air place (Other)
treadmill
干预措施: Walking exercises with treadmill (Other)
结局指标
主要结局
6-minute walk test
时间窗: First day of treatment, at the end of 4 week
次要结局
- Short Form-36 (SF-36)(First day of treatment, at the end of 4 week)
- Beck Depression Scale(First day of treatment, at the end of 4 week)
- Fibromyalgia Impact Questionnaire (FIQ)(First day of treatment, at the end of 4 week)
- Measurement of maximum inspiratory and expiratory pressure (MIP) and (MEP)(First day of treatment, at the end of 4 week)
- Fatigue Impact Scale(First day of treatment, at the end of 4 week)
研究者
Ayse Naz Kalem
PM&R Specialist
Ankara Etlik City Hospital